Cutler Group LP Cassava Sciences Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Cassava Sciences Inc stock. As of the latest transaction made, Cutler Group LP holds 11,700 shares of SAVA stock, worth $257,751. This represents 0.08% of its overall portfolio holdings.

Number of Shares

11,700

Previous 31,477 62.83%

Holding current value

$257,751

Previous $708,000 66.53%

% of portfolio

0.08%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$18.44 - $26.41 $364,687 - $522,310	-19,777 Reduced 62.83%	11,700 $237,000
Q4 2023 Jan 18, 2024	BUY	$12.64 - $30.11 $377,645 - $899,596	29,877 Added 1867.31%	31,477 $708,000
Q3 2023 Nov 07, 2023	SELL	$16.64 - $25.32 $58,240 - $88,620	-3,500 Reduced 68.63%	1,600 $26,000
Q2 2023 Jul 18, 2023	SELL	$21.59 - $27.88 $15,113 - $19,516	-700 Reduced 12.07%	5,100 $125,000
Q1 2023 May 01, 2023	SELL	$23.46 - $36.44 $396,474 - $615,836	-16,900 Reduced 74.45%	5,800 $139,000

Q4 2022 Feb 07, 2023	BUY	$27.82 - $44.16 $41,730 - $66,240	1,500 Added 7.08%	22,700 $670,000
Q3 2022 Oct 25, 2022	BUY	$16.33 - $51.06 $183,549 - $573,914	11,240 Added 112.85%	21,200 $886,000
Q2 2022 Aug 04, 2022	BUY	$17.22 - $38.47 $13,087 - $29,237	760 Added 8.26%	9,960 $280,000
Q1 2022 Apr 14, 2022	BUY	$32.6 - $53.05 $88,020 - $143,235	2,700 Added 41.54%	9,200 $341,000
Q4 2021 Jan 18, 2022	SELL	$36.77 - $90.91 $456,389 - $1.13 Million	-12,412 Reduced 65.63%	6,500 $284,000
Q3 2021 Oct 26, 2021	BUY	$41.79 - $135.3 $75,807 - $245,434	1,814 Added 10.61%	18,912 $1.17 Million
Q2 2021 Jul 19, 2021	BUY	$32.15 - $89.72 $9,709 - $27,095	302 Added 1.8%	17,098 $1.46 Million
Q1 2021 Apr 26, 2021	BUY	$7.09 - $87.95 $93,559 - $1.16 Million	13,196 Added 366.56%	16,796 $754,000
Q4 2020 Jan 21, 2021	BUY	$6.79 - $12.25 $1,188 - $2,143	175 Added 5.11%	3,600 $24,000
Q3 2020 Oct 27, 2020	SELL	$2.86 - $11.51 $3,360 - $13,524	-1,175 Reduced 25.54%	3,425 $39,000
Q2 2020 Jul 22, 2020	BUY	$2.04 - $9.64 $1,428 - $6,748	700 Added 17.95%	4,600 $14,000
Q1 2020 May 07, 2020	BUY	$3.26 - $9.65 $12,714 - $37,635	3,900 New	3,900 $16,000

Others Institutions Holding SAVA

# of Institutions

172

Shares Held

11.3M

Call Options Held

1.61M

Put Options Held

1.43M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $883M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account